CDKN2A and neoplasm: Tumor markers associated with the modifications at the genes’ level (TP53, RAS, HER-2/neu, RET, BCL2, BCL1-PRAD1-CCND1, REL, MYC, BCL6, p16-INK4a-CDKN2A).